Product Browser

Last updated: 2016/11/27

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

ST7 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00007982-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-ST7 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 62.8
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-ST7 antibody (H00007982-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00007982-T01
    ST7 transfected lysate.
    Western Blot
    QC Testing of H00007982-T01
    Lane 1: ST7 transfected lysate ( 62.8 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 7982
  • Gene Name:
  • ST7
  • Gene Alias:
  • DKFZp762O2113,ETS7q,FAM4A,FAM4A1,HELG,RAY1,SEN4,TSG7
  • Gene Description:
  • suppression of tumorigenicity 7
  • Gene Summary:
  • The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described. [provided by RefSeq
  • Other Designations:
  • family with sequence similarity 4, subfamily A, member 1,suppression of tumorigenicity 7 (breast)
  • RSS
  • YouTube
  • Linkedin
  • Facebook